Tianjin Chase Sun Pharmaceutical Co., Ltd. logo

Tianjin Chase Sun Pharmaceutical Co., Ltd. (300026)

Market Open
11 Aug, 06:57
XSHE XSHE
¥
3. 56
+0.15
+4.3988%
¥
11.18B Market Cap
- P/E Ratio
0.12% Div Yield
54.5M Volume
- Eps
¥ 3.41
Previous Close
Add Transaction
Day Range
3.42 3.59
Year Range
2.82 4.44
Want to track 300026 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Tianjin Chase Sun Pharmaceutical Co., Ltd. (300026) Statistics

Valuation metrics

Market Cap 11.18B
Enterprise value 9.2B
Trailing P/E (ttm) 410.84
Forward P/E -
PEG ratio -0.13
Price/Sales (ttm) 2.19
Price/Book (mrq) 1.31
Enterprise Value/Revenue 1.97
Enterprise Value/EBITDA 27.35

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 51.71M
Average volume (90 days) 45.18M

Price summary

52-Week low 2.82
52-Week high 4.44
Beta -
50-Day moving average 3.24
200-Day moving average 3.4

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.01
Trailing annual dividend yield 0.0029%
5-Year annual dividend yield -
Payout ratio 7.75
Dividend Date 15 Jul 2026
Ex-Dividend Date 15 Jul 2026
Last split factor 30:10
Last split Date 26 Oct 2016

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin 0.01%
Operating margin 0.03%

Operational effectiveness

Return on assets 0%
Return on equity 0%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 1.42
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.01
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 0.47
Total debt (mrq) -
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 4.7%
Book value per share (mrq) 2.65

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -